Tumour-experienced T cells promote NK cell activity through trogocytosis of NKG2D and NKp46 ligands
about
Enhanced cytotoxicity of natural killer cells following the acquisition of chimeric antigen receptors through trogocytosisEngineering lymph node homing of ex vivo-expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7.Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma.Mechanisms of cellular communication through intercellular protein transfer.Secretory pathways generating immunosuppressive NKG2D ligands: New targets for therapeutic intervention.Trans-SILAC: sorting out the non-cell-autonomous proteome.
P2860
Tumour-experienced T cells promote NK cell activity through trogocytosis of NKG2D and NKp46 ligands
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumour-experienced T cells pro ...... sis of NKG2D and NKp46 ligands
@en
Tumour-experienced T cells pro ...... is of NKG2D and NKp46 ligands.
@nl
type
label
Tumour-experienced T cells pro ...... sis of NKG2D and NKp46 ligands
@en
Tumour-experienced T cells pro ...... is of NKG2D and NKp46 ligands.
@nl
prefLabel
Tumour-experienced T cells pro ...... sis of NKG2D and NKp46 ligands
@en
Tumour-experienced T cells pro ...... is of NKG2D and NKp46 ligands.
@nl
P2093
P2860
P50
P356
P1433
P1476
Tumour-experienced T cells pro ...... sis of NKG2D and NKp46 ligands
@en
P2093
Damián E Avila
Gabriel A Rabinovich
Lucas E Rossi
María V Girart
P2860
P304
P356
10.1038/EMBOR.2009.92
P577
2009-06-05T00:00:00Z